Evidence map›Paper›PMID 33478470›Full record

ArticleBMC public health2021

Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d'Ivoire, Mali and Senegal.

Nicolas Rouveau, Odette Ky-Zerbo, Sokhna Boye, Arlette Simo Fotso, Marc d'Elbée, Mathieu Maheu-Giroux, Romain Silhol, Arsène Kra Kouassi, Anthony Vautier, Clémence Doumenc-Aïdara and 10 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 5 countries.

Nicolas RouveauCeped (Centre Population & Développement UMR 196), IRD, Université de Paris, Inserm, Paris, France. nicolas.rouveau@ceped.org.ORCID 0000-0002-5621-4230
Odette Ky-ZerboInstitut de Recherche pour le Développement, Transvihmi (UMI 233 IRD, 1175 INSERM, Montpellier University), Montpellier, France.
Sokhna BoyeCeped (Centre Population & Développement UMR 196), IRD, Université de Paris, Inserm, Paris, France.ORCID 0000-0002-8433-0992
Arlette Simo FotsoCeped (Centre Population & Développement UMR 196), IRD, Université de Paris, Inserm, Paris, France.ORCID 0000-0002-5006-8105
Marc d'ElbéeDepartment of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-8827-019X
Mathieu Maheu-GirouxDepartment of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montréal, QC, H3A 1A2, Canada.ORCID 0000-0002-8363-4388
Romain SilholAnalysis Department of Infectious Disease Epidemiology, Medical Research Council Centre for Global Infectious Disease, Imperial College London, London, UK.ORCID 0000-0002-5750-7609
Arsène Kra KouassiCeped (Centre Population & Développement UMR 196), IRD, Université de Paris, Inserm, Paris, France.ORCID 0000-0003-4928-6735
Anthony VautierSolthis, Dakar, Sénégal.ORCID 0000-0001-8039-6479
Clémence Doumenc-AïdaraSolthis, Dakar, Sénégal.ORCID 0000-0001-9595-2095
Guillaume BretonSolthis, Paris, France.
Abdelaye KeitaInstitut National de Recherche en Santé Publique (INRSP), Bamako, Mali.
Eboi EhuiProgramme National de Lutte contre le Sida, Abidjan, Côte d'Ivoire.
Cheikh Tidiane NdourDivision de Lutte contre le Sida et les IST, Ministère de la Santé et de l'Action sociale, Dakar, Sénégal.
Marie-Claude BoillyAnalysis Department of Infectious Disease Epidemiology, Medical Research Council Centre for Global Infectious Disease, Imperial College London, London, UK.ORCID 0000-0003-3919-006X
Fern Terris-PrestholtDepartment of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-1693-5196
Dolorès PouretteCeped (Centre Population & Développement UMR 196), IRD, Université de Paris, Inserm, Paris, France.ORCID 0000-0002-3599-8806
Alice DesclauxInstitut de Recherche pour le Développement, Transvihmi (UMI 233 IRD, 1175 INSERM, Montpellier University), Montpellier, France.
Joseph LarmarangeCeped (Centre Population & Développement UMR 196), IRD, Université de Paris, Inserm, Paris, France.ORCID 0000-0001-7097-700X
ATLAS Team
Inserm · FRImperial College London · GBInstitut National de Recherche en Santé Publique · MLLondon School of Hygiene & Tropical Medicine · GB

Funding

Medical Research Council MR/R015600/1Unitaid 2018-23-ATLAS
6 · The paper itself

Abstract

backgroundThe ATLAS programme aims to promote and implement HIV self-testing (HIVST) in three West African countries: Côte d'Ivoire, Mali, and Senegal. During 2019-2021, in close collaboration with the national AIDS implementing partners and communities, ATLAS plans to distribute 500,000 HIVST kits through eight delivery channels, combining facility-based, community-based strategies, primary and secondary distribution of HIVST. Considering the characteristics of West African HIV epidemics, the targets of the ATLAS programme are hard-to-reach populations: key populations (female sex workers, men who have sex with men, and drug users), their clients or sexual partners, partners of people living with HIV and patients diagnosed with sexually transmitted infections and their partners. The ATLAS programme includes research support implementation to generate evidence for HIVST scale-up in West Africa. The main objective is to describe, analyse and understand the social, health, epidemiological effects and cost-effectiveness of HIVST introduction in Côte d'Ivoire, Mali and Senegal to improve the overall HIV testing strategy (accessibility, efficacy, ethics).

methodsATLAS research is organised into five multidisciplinary workpackages (WPs): Key Populations WP: qualitative surveys (individual in-depth interviews, focus group discussions) conducted with key actors, key populations, and HIVST users. Index testing WP: ethnographic observation of three HIV care services introducing HIVST for partner testing. Coupons survey WP: an anonymous telephone survey of HIVST users. Cost study WP: incremental economic cost analysis of each delivery model using a top-down costing with programmatic data, complemented by a bottom-up costing of a representative sample of HIVST distribution sites, and a time-motion study for health professionals providing HIVST. Modelling WP: Adaptation, parameterisation and calibration of a dynamic compartmental model that considers the varied populations targeted by the ATLAS programme and the different testing modalities and strategies. DISCUSSION: ATLAS is the first comprehensive study on HIV self-testing in West Africa. The ATLAS programme focuses particularly on the secondary distribution of HIVST. This protocol was approved by three national ethic committees and the WHO's Ethical Research Committee.

Indexed as

HIV InfectionsSexual and Gender MinoritiesSex WorkersCote d'IvoireFemaleHomosexuality, MaleHumansMaleMaliSelf-TestingSenegalCôte d’IvoireHIV/AIDSHIV self-testingMaliSenegalWest Africa

Identifiers

PMID33478470
PMCPMC7818756
OpenAlexW3125254382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.